Origen Dbm With Bioactive Glass, Nanofuse Dbm
Filler, Bone Void, Calcium Compound. 510(k) K110976, from Nanotherapeutics, Inc. (Alachua, FL). Product code MQV, class 2.
As of Nov 17, 2026, K110976 is an FDA 510(k) held by Nanotherapeutics, Inc., substantially equivalent on May 3, 2011 after 26 days, with 2 recalls tied to it in FDA's recall database.
- Substantially equivalent: May 3, 2011
- Review time: 26 days
- Recalls: 2
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFOrigen DBM® with Bioactive Glass (NanoFUSE® DBM) is indicated to be gently placed into bony voids or gaps of the skeletal system that are not intrinsic to the stability of the bony structure. It is indicated to be placed into bony voids or gaps of the skeletal structure (e.g., the extremities and pelvis).
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Origen Dbm With Bioactive GlassK062459 · Nanotherapeutics · Feb 26, 2007
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- Nanofuse DbmK120279 · Nanotherapeutics · Apr 6, 2012
Recalls
Recalls FDA ties to K110976, newest first; each opens FDA's recall record| Mar 10, 2011 | Z-0347-2012On 03/10/2011 Nanotherapeutics Inc, Alachua, FL initiated a recall of their Origen DBM with Bioactive Glass Catalog # 22-2002 (2cc), 22-2005 (5cc) and 22-2010 (10cc). The same product is also distributed as NanoFUSE DBM… | Terminated |
| Mar 10, 2011 | Z-0346-2012On 03/10/2011 Nanotherapeutics Inc, Alachua, FL initiated a recall of their Origen DBM with Bioactive Glass Catalog # 22-2002 (2cc), 22-2005 (5cc) and 22-2010 (10cc). The same product is also distributed as NanoFUSE DBM… | Terminated |
Other MQV Clearances
The newest 510(k)s for the same product code; their median review was 96 days; see every MQV device- Mg OSTEOREVIVE;Mg OSTEOCRETEK262230 · Bone Solutions, Inc. · Sep 11, 2026
- Device 300419 StripK260364 · Geistlich Pharma AG · Jun 2, 2026
- JAZBI Resorbable Bone Void FillerK252797 · Sdip Innovations Pty, Ltd. · May 26, 2026
- Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip; Vitoss® BiModal Bioactive…K261008 · Stryker Spine · Apr 24, 2026
- Adaptos®Fuse Bone GraftK253524 · Biomendex OY · Feb 17, 2026
- FIBERGRAFT BG Putty GPS Bone Graft Substitute FIBERGRAFT BG Putty Bone Graft Substitute…K253147 · Prosidyan, Inc. · Oct 22, 2025
- Mg OSTEOINJECT; Mg OSTEOREVIVE; Mg OSTEOCRETEK251522 · Bone Solutions, Inc. · Oct 13, 2025
- Allomatrix (Allomatrix Injectable Putty; Allomatrix C; Allomatrix DR; Allomatrix Custom)K252085 · Wright Medical Technology, Inc. (Stryker Corporation) · Sep 30, 2025
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Apr 7, 2011
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3045
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files